High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells

Seiji Nagano(Kyoto University), Hiroshi Kawamoto(Fujita Health University), Hiroshi Ichise(Kyoto University), Akifumi Takaori‐Kondo(Kyoto University), Mahito Nakanishi(Tokiwa University), Manami Ohtaka(National Institute of Advanced Industrial Science and Technology), Kyoko Masuda(Kyoto University), Soki Kashima(Akita University), Takuya Maeda(Kyoto University), Norimitsu Kadowaki(Kagawa University)
Molecular Therapy — Methods & Clinical Development
December 24, 2019
10.1016/j.omtm.2019.12.006
Cited by 37

Related Papers

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
|Nature|2022|1.2k
Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity
|The Journal of Experimental Medicine|2000|837
Characterization of oligonucleotide transport into living cells.
|Proceedings of the National Academy of Sciences|1989|740
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
|Nature|2021|680
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633